FDA 483 - Trigen Laboratories - November 15, 2019

An FDA inspection of Trigen Laboratories, Inc. in Tampa, FL, a medical device manufacturer, revealed significant deficiencies in their quality system. The firm lacked adequate written procedures for handling customer complaints, managing Medical Device Reportable events, and controlling purchased products and services from suppliers. These issues indicate a failure to establish and maintain essential quality controls for medical device manufacturing.